Acer Therapeutics Inc.·4

Jan 20, 4:21 PM ET

Schelling Chris 4

4 · Acer Therapeutics Inc. · Filed Jan 20, 2021

Insider Transaction Report

Form 4
Period: 2021-01-15
Schelling Chris
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-01-15+40,00040,000 total
    Exercise: $3.85Exp: 2031-01-15Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on January 15, 2022, and the remaining 75% of the shares vest quarterly over the remaining three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION